NCT05430373 2026-04-14GT101 Injection for the Treatment of Metastatic or Recurrent Solid TumorsGrit BiotechnologyPhase 1 Recruiting31 enrolled
NCT05861895 2026-04-07HF158K1 in Patients With HER-2 Expressing Advanced Solid TumorsHighField Biopharmaceuticals CorporationPhase 1 Recruiting84 enrolled
NCT07396584 2026-03-27HMPL-A580 in Participants With Advanced or Metastatic Solid TumorHutchmedPhase 1/2 Recruiting186 enrolled